Buprenorphine versus methadone maintenance treatment in an ambulant setting: A health-related quality of life assessment

Addiction

Volumn 98, Issue 5, 2003, Pages 693-702

  Giacomuzzi, S M ^a,b   Riemer, Y ^a   Ertl, M ^a   Kemmler, G ^a   Rossler H ^a   Hinterhuber, H ^a   Kurz, M ^a  

^a University Department of Psychiatry   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Buprenorphine; Maintenance treatment; Methadone; Quality of life

Indexed keywords

BUPRENORPHINE; METHADONE;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COLD STRESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLOW UP; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PHYSICAL EXAMINATION; QUALITY OF LIFE; STOMACH PAIN; TREATMENT OUTCOME; URINALYSIS; URINE LEVEL;

ADULT; BUPRENORPHINE; FEMALE; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0037765040     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2003.00352.x     Document Type: Article

References (64)

1. Albert, S. M. (1998) Defining and measuring quality of life in medicine. Journal of the American Medical Association, 279, 429.
2. Allison, P. J., Locker, D. & Feine, J. S. (1997) Quality of life; a dynamic construct. Journal of the Social Science Medicine, 45, 221-230.
3. Ball, J. C. & Ross, A. (1991) The Effectiveness of Methadone Maintenance Treatment. New York: Springer Verlag.
4. Barnett, P. G., Rodgers, J. H. & Bloch, D. A. (2001a) A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction, 95, 683-690.
5. Barnett, P. G., Zaric, G. S. & Brandeau, M. L. (2001b) The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction, 96, 1267-1278.
6. Bell, J. & Zador, D. (2000) A risk-benefit analysis of methadone maintenance treatment. Drug Safety, 22, 179-190.
7. Bertschy, G. (1995) Methadone maintenance treatment: an update. European Archives of Psychiatry and Clinical Neuroscience, 245, 114-124.
8. Bickel, W. K. & Amass, L. (1995) Buprenorphine treatment of opioid dependence: a review. Experimental and Clinical Psychopharmacology, 146, 111-118.
9. Bradley, B. P., Gossop, M., Philips, G. & Legarda, J. J. (1987) The development of an Opiate Withdrawal Scale (OWS). British Journal of Addiction, 82, 1139-1142.
10. Bullinger, M. (1991) Quality of life: definition, conceptualization and implications - a methodologist's view. Theoretical Surgery, 6, 143-148.
11. Caplehorn, J. R. M. & Ross, M. W. (1995) Methadone maintenance and the likelihood of risky needle-sharing. International Journal of the Addictions, 30, 685-698.
12. Diener, E. (1999) Subjective well being: three decades of progress. Psychological Bulletin, 125, 276-302.
13. Dole, V. P. & Nyswander, M. E. (1965) A medical treatment for diacetylmorphine (heroin) addiction. Journal of the American Medical Association, 193, 80-84.
14. Donald, A. (2001) What is quality of life? Journal of Evidence Based Medicine, 1, 1-6.
15. Eder, H., Fischer, G., Gomas, W., Jagsch, R., Stühlinger, G. & Kasper, S. (1998) Comparison of buprenorphine and methadone maintenance in opiate addicts. European Addiction Research, 4, 3-7.
16. Fallowfield, L. (2002) Science and society: quality of life: a new perspective for cancer patients. Nature Reviews Cancer, 2, 873-879.
17. Farquhar, M. (1995) Definitions of quality of life: a taxonomy. Journal of Advanced Nursing, 22, 502-508.
18. Fischer, G., Gombas, W., Eder, H., Jagsch, R., Peternell, A., Stuhlinger, G., Pezawas, L., Aschauer, H. N. & Kasper, S. (1999) Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction, 94, 1337-1347.
19. Garg, N., Yates, W. R., Jones, R., Zhou, M. & Williams, S. (1999) Effect of gender, treatment site and psychiatric comorbidity on quality of life outcome in substance dependence. American Journal of Addiction, 8, 44-54.
20. Giacomuzzi, S. M., Riemer, Y., Kemmler, G., Ertl, M., Richter, R., Rössler, H. & Hinterhuber, H. (2001) Substitutionsbehandlung und Lebensqualität: Methadon vs. Retardiertes Morphinsulfat - eine Vergleichsstudie [Substitution treatment and quality of life: methadone vs. retard morphine sulfate - a comparative study]. Suchtmed. 3, 89-95.
21. Gossop, M. (1990) The development of a Short Opiate Withdrawal Scale (SOWS). Addictive Behaviors, 15, 487-490.
22. Gossop, M., Bradley, B. & Philips, G. T. (1987) An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure. Addiction, 12, 1-6.
23. Gross, A., Jacobs, E. A., Petty, N. M., Badger, G. J. & Bickel, W. K. (2001) Limits to buprenorphine dosing: a comparison between quintuple and sextuple the maintenance dose every 5 days. Drug and Alcohol Dependence, 64, 111-116.
24. Groß, A. & Soyka, M. (1999) Buprenorphin, ein neuer Ansatz in der Pharmakotherapie opiatabhängiger Patienten [Buprenorphine - a new approach in pharmacotherapy for opiate-dependent patients]. Suchtmedizin in Forschung und Praxis, 1, 5-14.
25. Holme, S. A. & Fleming, C. J. (2002) Cosmetic camouflage advice improves quality of life. British Journal of Dermatology, 147, 946-949.
26. Huxley, P., Evans, S., Burns, T., Fahy, T. & Green, J. (2001) Quality of life outcome in a randomized controlled trial of case management. Social Psychiatry and Psychiatric Epidemiology. 36, 249-255.
27. Huxley, P., Oliver, J., Priebe, S. & Kaiser, W. (1997) Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile, Social Psychiatry and Psychiatric Epidemiology, 32, 76-83.
28. Jasinski, D. R., Pevnick, J. & Griffith, J. (1978) Human pharmacology and abuse potential of the analgesic buprenorphine. Archives of General Psychiatry, 35, 501-516.
29. Johnson, R. E., Jaffe, J. H. & Fudala, P. J. (1992) A controlled trial buprenophine treatment for opioid dependence. Journal of the American Medical Association, 267, 2750-2755.
30. Katschnig, H., Freemann, H. & Sartorius, N., eds (1997) Quality of Life of Mental Disorders. Chichester/New York: Wiley.
31. Kirn, T. F. (1988) Methadone maintenance treatment remains controversial even after 23 years of experience. Journal of the American Medical Association. 260, 2970-2975.
32. Kolar, A. F., Brown, B. S., Weddington, W. W. & Ball, J. C. (1990) A treatment crisis: cocaine use by clients in methadone maintenance programs. Journal of Substance Abuse Treatment, 7, 101-107.
33. Kosten, T. R., Schottenfeld, R., Ziedonis, D. & Falcioni, J. (1993) Buprenorphine versus methadone maintenance for opioid dependence. Journal of Nervous and Mental Disease, 181, 358-364.
34. Leavitt, S., Shinderman, M., Maxwell, S., Eap, C. & Paris, P. (2000) When 'enough' is not enough: new perspectives on optimal methadone maintenance dose. Mount Sinai Journal of Medicine, 67, 404-411.
35. Leplège, A. & Hunt, S. (1997) The problem of quality of life in medicine. Journal of the American Medical Association, 278, 47-50.
36. Ling, W., Charuvastra, C., Collins. J. F., Batki, S., Brown, L. S., Kintaudi, P., Wesson, D. R., McNicholas, L., Tusel, D. J., Malkerneker, U., Renner, J. A. Jr. Santos, E., Casadonte, P., Fye, C., Stine, S., Wang, R. I. & Segal, D. (1998) Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction, 93, 475-486.
37. Ling, W., Wesson, D., Charuvastra, C. & Klett, J. (1996) A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry, 53, 401-407.
38. Martin, J., Payte, J. T. & Zweben, J. E. (1991) Methadone maintenance treatment: a primer for physicians. Journal of Psychoactive Drugs, 23, 165-176.
39. Maxwell, S. & Shinerman, M. S. (2002) Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone. Journal of Addicitive Diseases, 21, 1-12.
40. Muldoon, M. F., Barger, S. D., Flory, J. D. & Manuck, S. B. (1998) What are quality of life measurements measuring? British Medical Journal, 316, 542-545.
41. Newman, R. G. (1987) Methadone treatment. New England Journal of Medicine, 317, 447-450.
42. Oliver, J. (1991) The Social Care Directive: development of a quality of life profile for use in community services for the mentally ill. Social Work and Social Sciences Review, 3, 5-45.
43. Oliver, J., Huxley, P., Bridges, K. & Mohamed, H. (1996) Quality of Life and Mental Health Services. London: Routledge.
44. Pani, P. P., Maremmani, I., Piratsu, R., Tagliamonte, A. & Gessa, G. L. (2000) Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. Journal of Drug and Alcohol Dependence, 60, 39-50.
45. Petry, N. M., Bickel, W. K. & Badger, G. J. (2000) A comparison of four buprenorphine dosing regimens using open-dosing procedures: is twice-weekly dosing possible? Addiction, 95, 1069-1077.
46. Petry, N. M., Bickel, W. K. & Badger, G. J. (2001) Examining the limits of the buprenorphine interdosing interval: daily, every-third-day and every-fifth-day dosing regimens. Addicition, 96, 823-834.
47. Priebe, S., Gruyters, T., Heinze. M., Hoffmann, C. & Jäkel, A. (1995) Subjektive Evaluationskriterien in der psychiatrischen Versorgung - Erhebungsmethoden für Forschung und Praxis. Psychiatrische Praxis, 22, 140-144.
48. Ritsner, M., Modai, I., Kurs, R., Kostizky, H. & Ponizovsky, A. (2001) A comparison between the Hebrew versions of the Quality of Life Enjoyment and Satisfaction Questionnaire and the Lancashire Quality of Life Profile in severely mentally ill patients. Quality of Life Newsletter, 26, 12-13.
49. Ruggeri, M., Bisoffi, G., Fontecedro, L. & Warner, R. (2001) Subjective and objective dimensions of quality of life in psychiatric patients: a factor analytical approach: the South Verona Outcome Project 4. British Journal of Psychiatry, 178, 268-275.
50. Scherbamn, N., Finkbeiner, T., Leifert, K. & Gastpar, M. (1996) The efficacy of L-methadone and racemic methadone in substitution treatment of opiate addicts - a double-blind comparison. Pharmacopsychiatry, 29, 212-215.
51. Schoenbaum, H. & Selwyn, P. A. (1995) Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. American Journal of Public Health, 85, 83-88.
52. Schottenfeld, R. S., Pakes, J. R. & Kosten, T. (1998) Prognostic factors in buprenorphine versus methadone maintained patients. Journal of Nervous and Mental Disease, 186, 713-720.
53. Schwartz, R. P., Brooner, R. K., Montoya, I. D., Currens, M. & Hayes, M. (1999) A 12-year follow-up of a methadone medical maintenance program. American Journal of Addiction, 8, 293-299.
54. Strain, E. C., Stitzer, M. L., Liebson, I. A. & Bigelow, G. E. (1994) Comparison of buprenorphine and methadone in the treatment of opioid dependence. American Journal of Psychiatry, 151, 1025-1030.
55. Sutherland, H. J. & Till, J. E. (1993) Quality of life assessments and levels of decision making: differentiating objectives. Qualilty of Life Research, 4, 297-303.
56. Till, J. E. (1994) Measuring quality of life: apparent benefits, potential concerns. Canadian Journal of Oncology, 4, 243-248.
57. Torrens, M., Domingo-Salvany, A., Alonso, J., Castillo, C. & San, L. (1999) Methadone and quality of life. Lancet, 353, 1101.
58. Torrens, M., San, L., Martinez, A., Castillo, C., Domingo-Salvany, A. & Alonso, J. (1997) Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction, 92, 707-716.
59. Uehlinger, C., Deglon, J. J., Livoti, S., Petitjean, S., Waldvogel, D. & Ladewig, D. (1998) Comparison of buprenorphine and methadone in the treatment of opioid dependence. European Addiction Research, 4, 13-18.
60. Van Nieuwenhuizen, C., Schene, A. H., Koeter, M. W. & Huxley, P. (2001) The Lancashire Quality of Life Profile: modification and psychometric evaluation. Journal of Social Psychiatry and Psychiatric Epidemiology, 36, 36-44.
61. Vignau, J. & Brunelle, E. (1998) Differences between general practitioner- and addiction centre-prescribed substitution therapy in France. Preliminary results. European Addiction Research, 1, 24-28.
62. Walsh, S. L., Preston, K. L., Bigelow, G. E. & Stitzer, M. L. (1995) Acute administration of buprenorphine in humans: partial agonist and blockade effects. Journal of Pharmacology and Experimental Therapeutics, 274, 361-372.
63. West, S. L., O'Neal, K. K. & Graham, C. W. (2000) A meta-analysis comparing the effectiveness of buprenorphine and methadone. Journal of Substance Abuse, 12, 405-414.
64. Zaric, G. S., Barnett, P. G. & Brandeau, M. L. (2000) HIV transmission and the cost effectiveness of methadone maintenance. American Journal of Public Health, 90, 1100-1111.